June 19, 2024 06:57 AM EDTUpdated June 20, 08:49 AM
Financing

Blank check, please? Three health­care SPACs re­veal their IPO plans

Kyle LaHucik

Senior Reporter

SPACs might nev­er ful­ly go away if the am­bi­tions of three new health­care-fo­cused shops have any sway.

As ini­tial pub­lic of­fer­ings are far and few …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Why the Supreme Court's over­rule of Chevron has ma­jor im­pli­ca­tions for the FDA

J&J de­tails Phase 3 suc­cess of au­toim­mune dis­ease drug, tout­ing broad­er range than ar­genx’s Vyv­gart

Sci­en­tists un­veil new way to make large changes to genes, and no CRISPR is re­quired

FDA re­jects Rock­et Phar­ma’s ul­tra-rare im­mune dis­ease gene ther­a­py over man­u­fac­tur­ing

In­side BAR­DA's multi­bil­lion-dol­lar ef­fort to fund long-shot biotechs for Covid

New can­cer biotech emerges from Stan­ford re­search, with help of No­bel lau­re­ate Car­olyn Bertozzi

A service from the Financial Times